# Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial

> **NCT00250991** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Cincinnati** · enrollment: 94 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** activase
- **DRUG:** integrilin

## Key facts

- **NCT ID:** NCT00250991
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2009-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00250991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00250991, "Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00250991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*